Literature DB >> 25681838

Ovulation induction.

Johanna Von Hofe1, G Wright Bates2.   

Abstract

Before initiating ovulation induction, it is important to evaluate the underlying cause of a patient's anovulation and to make lifestyle modifications or treat underlying medical conditions, as appropriate. Here, ovulation induction agents are discussed with attention to their pharmacology, indications for use, therapy regimens, and efficacy. Adjuvant therapies and appropriate monitoring are also reviewed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clomiphene citrate; Gonadotropins; Letrozole; Ovulation induction; Ovulation monitoring

Mesh:

Substances:

Year:  2014        PMID: 25681838     DOI: 10.1016/j.ogc.2014.09.007

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  4 in total

Review 1.  Clomiphene for anovulatory infertility.

Authors:  Riley Davidson; Tarek Motan; Christina Korownyk
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

Review 2.  Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Quang-Khoi Le; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-09-27

Review 3.  Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.

Authors:  Sebastian Franik; Stephanie M Eltrop; Jan Am Kremer; Ludwig Kiesel; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2018-05-24

4.  Transcutaneous electrical acupoint stimulation improves endometrial receptivity resulting in improved IVF-ET pregnancy outcomes in older women: a multicenter, randomized, controlled clinical trial.

Authors:  Xiaojun Feng; Na Zhu; Shuo Yang; Li Wang; Wei Sun; Rong Li; Fei Gong; Songping Han; Rong Zhang; Jisheng Han
Journal:  Reprod Biol Endocrinol       Date:  2022-08-22       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.